We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Your guide to a disrupted world
Add this topic to your myFT Digest for news straight to your inbox
Company’s first quarter sales and ebitda rose by more than a quarter, compared with a year before
The Swiss chemicals group was forced to delay its results this week after its auditors refused to sign off the annual accounts
Delayed results and a pending investigation into accounting irregularities have hit the company’s share price
Shares in Swiss chemicals group tumble as it investigates allegations of accounts manipulation
Swiss company announces ‘challenging’ results a day after its chief executive quit
Departure comes during negotiations with Saudi shareholder over joint venture
Swiss company picks Ernesto Occhiello from Saudi anchor shareholder to take reins
Profits dented because of money spent in defence of abandoned merger plan
Group backed by Corvex and 40 North sells 25% stake to Saudi Arabia’s Sabic
Corvex-backed White Tale Holdings had blocked $20bn Huntsman merger
This is a dispute for independent directors to settle
Strong sales — up 12 per cent in third quarter — suggest group can also ‘go it alone’
Swiss group also faces calls for strategy review after merger plans dropped
The hedge fund manager will have to threaten more active measures to get results
Chemicals groups admit defeat in face of opposition from US activist investors
Corvex and allies oppose plan to combine Swiss chemicals group with US rival Huntsman
Corvex’s Keith Meister is part of the next wave of activist hedge fund investors
40 North and Keith Meister’s Corvex take 7.2% stake in Swiss chemicals group
International Edition
